Upgrade to SI Premium - Free Trial

ResMed (RMD) PT Raised to $224 at Stifel

April 1, 2024 6:24 AM
(Updated - April 1, 2024 6:24 AM EDT)

Stifel analyst Mike Matson raised the price target on ResMed (NYSE ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change